RESULTS OF A REAL LIFE DOSE-REDUCTION STRATEGY FOR ANTI-TNFALPHA INHIBITORS IN A COHORT OF PATIENTS WITH SPONDYLOARTHRITIS

dc.conference.dateJUN 14-17, 2017
dc.conference.titleAnnual European Congress of Rheumatology
dc.contributor.authorCastro-Villegas, M. C.
dc.contributor.authorFont-Ugalde, P.
dc.contributor.authorRomero-Gomez, M.
dc.contributor.authorArredondo-Lopez, M.
dc.contributor.authorLopez-Medina, E. C.
dc.contributor.authorOrtega-Castro, R.
dc.contributor.authorCalvo-Gutierrez, J.
dc.contributor.authorEscudero-Contreras, A.
dc.contributor.authorCollantes-Estevez, E.
dc.contributor.authoraffiliation[Castro-Villegas, M. C.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Font-Ugalde, P.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Romero-Gomez, M.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Lopez-Medina, E. C.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Ortega-Castro, R.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Calvo-Gutierrez, J.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Escudero-Contreras, A.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Collantes-Estevez, E.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Castro-Villegas, M. C.] IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Font-Ugalde, P.] IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Romero-Gomez, M.] IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Ortega-Castro, R.] IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Calvo-Gutierrez, J.] IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Collantes-Estevez, E.] IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Font-Ugalde, P.] Univ Cordoba, Cordoba, Spain
dc.contributor.authoraffiliation[Arredondo-Lopez, M.] Univ Cordoba, Cordoba, Spain
dc.contributor.authoraffiliation[Calvo-Gutierrez, J.] Univ Cordoba, Cordoba, Spain
dc.contributor.authoraffiliation[Collantes-Estevez, E.] Univ Cordoba, Cordoba, Spain
dc.date.accessioned2025-01-07T13:27:59Z
dc.date.available2025-01-07T13:27:59Z
dc.date.issued2017-06-01
dc.identifier.doi10.1136/annrheumdis-2017-eular.2633
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/76/Suppl_2/350.1.full.pdf
dc.identifier.urihttps://hdl.handle.net/10668/25540
dc.identifier.wosID413181401063
dc.issue.number2
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
dc.page.number350-350
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.titleRESULTS OF A REAL LIFE DOSE-REDUCTION STRATEGY FOR ANTI-TNFALPHA INHIBITORS IN A COHORT OF PATIENTS WITH SPONDYLOARTHRITIS
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number76
dc.wostypeMeeting Abstract

Files